Treatment resistant impetigo herpetiformis treated with infliximab. (Record no. 29303820)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01233 a2200361 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250518021418.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201911s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1529-8019 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1111/dth.12839 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Ogrum, Atiye |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20191113 |
245 00 - TITLE STATEMENT | |
Title | Treatment resistant impetigo herpetiformis treated with infliximab. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Dermatologic therapy |
Date of publication, distribution, etc. | 03 2019 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | e12839 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Case Reports; Journal Article |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Dermatitis Herpetiformis |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Dermatologic Agents |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Therapy, Combination |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Impetigo |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Infliximab |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pregnancy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pregnancy Complications, Infectious |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Takci, Zennure |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Seckin, Havva Yildiz |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Cetin, Elif |
773 0# - HOST ITEM ENTRY | |
Title | Dermatologic therapy |
Related parts | vol. 32 |
-- | no. 2 |
-- | p. e12839 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1111/dth.12839">https://doi.org/10.1111/dth.12839</a> |
Public note | Available from publisher's website |
No items available.